Bruni J V & Co. Co. Has $20.16 Million Stake in Cigna Group $CI

Bruni J V & Co. Co. lowered its position in Cigna Group (NYSE:CI) by 34.6% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 69,948 shares of the health services provider’s stock after selling 37,008 shares during the quarter. Cigna Group makes up about 2.0% of Bruni J V & Co. Co.’s investment portfolio, making the stock its 22nd largest holding. Bruni J V & Co. Co.’s holdings in Cigna Group were worth $20,163,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Harbor Capital Advisors Inc. grew its holdings in Cigna Group by 119.5% during the third quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock worth $26,000 after purchasing an additional 49 shares during the period. Solstein Capital LLC acquired a new stake in shares of Cigna Group in the second quarter valued at approximately $29,000. Chilton Capital Management LLC bought a new position in shares of Cigna Group during the 2nd quarter worth approximately $30,000. Collier Financial acquired a new position in shares of Cigna Group during the 3rd quarter worth approximately $34,000. Finally, Quaker Wealth Management LLC raised its stake in Cigna Group by 201.0% in the 2nd quarter. Quaker Wealth Management LLC now owns 106 shares of the health services provider’s stock valued at $35,000 after acquiring an additional 211 shares during the period. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Cigna Group Stock Performance

NYSE CI opened at $280.41 on Friday. The firm has a 50-day moving average price of $278.91 and a two-hundred day moving average price of $284.18. Cigna Group has a 12-month low of $239.51 and a 12-month high of $350.00. The company has a market capitalization of $74.90 billion, a P/E ratio of 12.64, a P/E/G ratio of 0.97 and a beta of 0.27. The company has a quick ratio of 0.76, a current ratio of 0.74 and a debt-to-equity ratio of 0.74.

Cigna Group (NYSE:CI) last released its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, beating analysts’ consensus estimates of $7.88 by $0.20. The company had revenue of $72.50 billion during the quarter, compared to the consensus estimate of $69.53 billion. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The firm’s quarterly revenue was up 10.4% on a year-over-year basis. During the same period in the previous year, the business earned $6.64 earnings per share. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Analysts anticipate that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, March 19th. Investors of record on Thursday, March 5th will be given a $1.56 dividend. The ex-dividend date is Thursday, March 5th. This is an increase from Cigna Group’s previous quarterly dividend of $1.51. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. Cigna Group’s dividend payout ratio (DPR) is 27.23%.

Wall Street Analyst Weigh In

A number of research firms have commented on CI. Barclays reduced their price objective on shares of Cigna Group from $305.00 to $303.00 and set an “overweight” rating for the company in a research report on Friday, February 6th. Royal Bank Of Canada reduced their target price on shares of Cigna Group from $344.00 to $333.00 and set an “outperform” rating for the company in a report on Friday, February 6th. Morgan Stanley reissued an “overweight” rating and issued a $355.00 price target on shares of Cigna Group in a report on Friday, October 31st. UBS Group restated a “buy” rating and set a $375.00 price objective on shares of Cigna Group in a report on Monday, February 9th. Finally, Sanford C. Bernstein reaffirmed a “market perform” rating and issued a $307.00 target price on shares of Cigna Group in a research report on Tuesday, January 6th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat, Cigna Group presently has a consensus rating of “Moderate Buy” and an average target price of $330.63.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.